Changes in retinoblastoma gene expression during cervical cancer progression

Mauricio Salcedo1, Lucía Taja, Dolores Utrera

  • 1Oncology Research Unit, Oncology Hospital, National Medical Center SXXI-IMSS, Mexico. maosal89@yahoo.com

Insights

Tumour suppressor retinoblastoma (pRb) protein shows varied expression during cervical cancer development, with higher levels in pre-malignant lesions. This heterogeneous pRb staining pattern may play a role in uterine cervix carcinoma pathogenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Virology

Background:

  • Tumour suppressor genes are crucial in human cancer development.
  • High-risk human papillomavirus (HPV) is implicated in cervical carcinogenesis, inactivating retinoblastoma (pRb) and p53 proteins.
  • The expression patterns of these proteins in pre-malignant and malignant cervical tissues are not fully understood.

Purpose of the Study:

  • To investigate the in situ expression of retinoblastoma (pRb) protein in normal, pre-malignant (squamous intraepithelial lesions - SILs), and malignant cervical tissues.
  • To analyze the expression of c-Myc protein in these same cervical tissue types.
  • To correlate pRb and c-Myc expression patterns with the stages of cervical carcinogenesis.

Main Methods:

  • Immunostaining techniques were employed to detect pRb and c-Myc protein expression.
  • Cervical tissue samples included normal tissue, SILs, and invasive carcinomas.
  • Expression patterns were analyzed across these different histological grades.

Main Results:

  • Retinoblastoma (pRb) protein showed low detection in normal and invasive cervical tissues but significantly higher expression in SILs.
  • C-Myc protein was highly expressed in the nuclei of invasive cervical lesion cells but showed low expression in SILs.
  • A heterogeneous pRb immunodetection pattern was observed throughout the stages of cervical carcinogenesis.

Conclusions:

  • The observed heterogeneous pRb immunostaining pattern during cervical carcinogenesis suggests its potential involvement in the pathogenesis of uterine cervix carcinoma.
  • The distinct expression profiles of pRb and c-Myc in different cervical lesion stages provide insights into their roles in cancer development.
  • Further investigation into the role of pRb expression patterns could offer new diagnostic or therapeutic strategies for cervical cancer.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...